Tianyuan Xu
Papers
6
Total Citations
385
H-Index
6
About
Tianyuan Xu is a urological surgeon and researcher whose work has significantly advanced the evidence base for robot-assisted minimally invasive urological procedures. Specializing in comparative surgical outcomes and meta-analytic methodology, Xu has systematically evaluated the perioperative benefits and limitations of robotic surgery across multiple urological conditions, including renal cell carcinoma, bladder cancer, and prostate cancer. His most influential contribution — a 2016 systematic review comparing robot-assisted partial nephrectomy (RAPN) with open partial nephrectomy, which has garnered 139 citations — helped clarify the clinical trade-offs between these approaches at a time when robotic techniques were rapidly gaining adoption. Complementing this, his 2013 meta-analysis comparing RAPN with laparoscopic partial nephrectomy (72 citations) and his 2015 review of robotic versus open radical cystectomy (71 citations) collectively established him as a leading synthesizer of evidence in minimally invasive urology. Xu has also examined nuanced clinical questions, such as the impact of obesity on robotic prostatectomy outcomes and the comparative merits of transperitoneal versus retroperitoneal approaches to RAPN. His early clinical case series on robot-assisted resection of large retroperitoneal paraganglioma further demonstrates his hands-on surgical innovation. Collectively, his work has meaningfully informed surgical decision-making and training worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6